US-based telemedicine company Carena secured $13.3m in a series B round yesterday from investors including McKesson Ventures, the corporate venturing unit of healthcare IT company McKesson.
Non-profit health services provider Cambia Health Solutions, healthcare system Catholic Health Initiatives (CHI) and venture capital firm Martin Ventures also took part in the round.
Carena operates a telemedicine platform through which patients can receive consultations from qualified GPs through the phone or the internet. Appointments typically last for 20 minutes, with common conditions including sore throat, pink eye and cold typically treated.
The company will use the series B funding to expand its platform to hospitals, as it aims to double revenue this year.
CHI previously led a $14m series A round for Carena in 2012. According to regulatory filings, Carena also received $3.5m in seed funding in 2008, as well as a total of approximately $7.6m in debt financing between 2010 and April 2015.